These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7466196)

  • 1. [Dysmenorrhea: use of a slow-release beta-mimetic agent].
    Di Piazza D; Demaria E; Quaranta S; Turconi G; Vicariotto F
    Riv Ital Ginecol; 1980; 59(1):49-58. PubMed ID: 7466196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoxsuprine in primary dysmenorrhea. Its efficiency in premenstrual tension].
    Flores-Mercado F; Gallegos-Torres J
    Ginecol Obstet Mex; 1975 Oct; 38(228):279-87. PubMed ID: 1107164
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of isoxsuprine in essential dysmenorrhea. A controlled clinical study.
    Nesheim BI; Walloe L
    Acta Obstet Gynecol Scand; 1976; 55(4):315-6. PubMed ID: 788451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relief of pain in primary dysmenorrhoea by beta-adrenoceptor stimulating drugs.
    Akerlund M; Andersson KE
    Acta Obstet Gynecol Scand; 1977; 56(3):255-6. PubMed ID: 195441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isoxsuprine (Vasoplex). Review of literature on the experimental and clinical results].
    Teubner W
    Fortschr Med; 1972 May; 90(13):517-21. PubMed ID: 4680617
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoxsuprine in primary dysmenorrhoea. Its effectiveness in premenstrual tension.
    Gallegos-Torres J; Flores-Mercado F
    J Int Med Res; 1975; 3(3):194-201. PubMed ID: 162675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoxsuprine as a tocolytic agent: use in a community hospital.
    Koroly MV
    J Am Osteopath Assoc; 1982; 81(6 Suppl):413-6. PubMed ID: 7076525
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour.
    Raymajhi R; Pratap K
    Kathmandu Univ Med J (KUMJ); 2003; 1(2):85-90. PubMed ID: 16388203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Bromadryl F in dysmenorrhea].
    Tůmová Z; Cepelák J
    Act Nerv Super (Praha); 1968 Oct; 10(3):263-4. PubMed ID: 5702515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of dysmenorrhea].
    Lundström V
    Nord Med; 1986; 101(12):356-8. PubMed ID: 3808934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of an antispasmodic: 3697 CB in dysmenorrhea].
    Vitse M
    Lille Med; 1968; 13(6):Suppl 717-9. PubMed ID: 5684062
    [No Abstract]   [Full Text] [Related]  

  • 12. [New method for the therapeutic control of dysmenorrhea].
    Homem HS
    Rev Bras Med; 1968 May; 25(5):365-8. PubMed ID: 4387128
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial of a new synthetic product, 3697 CB in the treatment of dysmenorrhea].
    Fabre A
    Rev Fr Gynecol Obstet; 1966 Oct; 61(10):745-7. PubMed ID: 5983671
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with the treatment of primary dysmenorrhea].
    Horváth B; Turay A; Horváth S
    Orv Hetil; 1981 Apr; 122(14):823-5. PubMed ID: 7254808
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic results of the administration of antiserotonic drugs for dysmenorrhea].
    Maroudis DG; Lympiotakos P; Sotirakopoulos B
    Gynecol Obstet (Paris); 1968; 67(5):549-52. PubMed ID: 5730663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of a new therapeutic form of CB 3697 in the treatment of dysmenorrhea].
    Dorangeon P
    Rev Fr Gynecol Obstet; 1970 Jun; 65(6):385-7. PubMed ID: 5429861
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysmenorrhea in adolescents and young adults: etiology and management.
    Harel Z
    J Pediatr Adolesc Gynecol; 2006 Dec; 19(6):363-71. PubMed ID: 17174824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of conducting a placebo-controlled trial for dysmenorrhea in adolescents.
    Davis AR; Osborne LM; O'Connell KJ; Westhoff CL
    J Adolesc Health; 2006 Oct; 39(4):607-9. PubMed ID: 16982402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of dysmenorrhea with a mixed preparation of norethindrone and mestranol (S-3800C)].
    Karasawa Y
    Sanfujinka No Jissai; 1968 Oct; 17(10):913-8. PubMed ID: 5755772
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E; Wildemeersch P
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.